However, several other obstacles have to be tackled, such as a persistent autoimmunity, the period of thyroid hormone-suppressive therapy in the first phase of cancer treatment, and the security of organoids that harbor occult cancer cells. This evidence concerns the gene TG and Autoimmunity.